PPT-ALLY-3 Design Objective SVR
12 HCV RNA lt 25 IUml with 95 CI DCV 60 mg qd SOF 400 mg qd DCV 60 mg qd SOF 400 mg qd Not randomised Open label ALLY3 Study DCV SOF for HCV genotype 3 W12
Download Presentation
"ALLY-3 Design Objective SVR" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.